This IBM Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday

IBM Corp
Synopsys, Inc.
Apogee Therapeutics, Inc.
SpaceX
Faeth Therapeutics, Inc.

IBM Corp

IBM

0.00

Synopsys, Inc.

SNPS

0.00

Apogee Therapeutics, Inc.

APGE

0.00

SpaceX

SPCX

0.00

Faeth Therapeutics, Inc.

FTH

0.00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Piper Sandler analyst Clarke Jeffries upgraded Synopsys Inc (NASDAQ:SNPS) from Neutral to Overweight and raised the price target from $450 to $550. Synopsys shares closed at $464.58 on Monday. See how other analysts view this stock.
  • JP Morgan analyst Brian Essex upgraded IBM (NYSE:IBM) from Neutral to Overweight and raised the price target from $270 to $291. IBM shares closed at $252.22 on Monday. See how other analysts view this stock.
  • Citigroup analyst Nick Joseph upgraded American Healthcare REIT, Inc. (NYSE:AHR) from Neutral to Buy and maintained the price target of $55. American Healthcare shares closed at $47.16 on Monday. See how other analysts view this stock.

Considering buying CHWY stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.